PL2081562T3 - Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu - Google Patents

Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu

Info

Publication number
PL2081562T3
PL2081562T3 PL07842927T PL07842927T PL2081562T3 PL 2081562 T3 PL2081562 T3 PL 2081562T3 PL 07842927 T PL07842927 T PL 07842927T PL 07842927 T PL07842927 T PL 07842927T PL 2081562 T3 PL2081562 T3 PL 2081562T3
Authority
PL
Poland
Prior art keywords
methods
pain relief
regional anesthesia
volatile anesthetics
delivering volatile
Prior art date
Application number
PL07842927T
Other languages
English (en)
Inventor
Phillip C. Phan
Allen W. Burton
Original Assignee
The Board Of Regents Of The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Regents Of The University Of Texas System filed Critical The Board Of Regents Of The University Of Texas System
Publication of PL2081562T3 publication Critical patent/PL2081562T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL07842927T 2006-09-20 2007-09-20 Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu PL2081562T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84629306P 2006-09-20 2006-09-20
US94721907P 2007-06-29 2007-06-29

Publications (1)

Publication Number Publication Date
PL2081562T3 true PL2081562T3 (pl) 2017-05-31

Family

ID=39092912

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07842927T PL2081562T3 (pl) 2006-09-20 2007-09-20 Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu

Country Status (9)

Country Link
US (3) US20080119820A1 (pl)
EP (1) EP2081562B1 (pl)
JP (4) JP2010504359A (pl)
AU (1) AU2007299738B2 (pl)
CA (1) CA2663857C (pl)
DK (1) DK2081562T3 (pl)
ES (1) ES2573253T3 (pl)
PL (1) PL2081562T3 (pl)
WO (1) WO2008036858A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2721701B2 (ja) 1989-04-20 1998-03-04 株式会社千代田製作所 有機溶剤を使用する洗浄装置の運転方法
WO2009094460A2 (en) 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
EP3581169A1 (en) * 2008-01-22 2019-12-18 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
AU2015200210B2 (en) * 2008-01-22 2016-08-11 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
WO2010025505A1 (en) * 2008-09-04 2010-03-11 Phebra Pty Ltd Analgesia by transmucosal administration
WO2010129686A1 (en) 2009-05-05 2010-11-11 Vapogenix, Inc. Novel formulations of volatile anesthetics and methods of use for reducing inflammation
DE102010042615A1 (de) * 2010-10-19 2012-04-19 Wacker Chemie Ag 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel
US9968540B2 (en) * 2011-06-24 2018-05-15 Vapogenix, Inc. Formulations and methods for treating dermatological disorders or diseases
CN112933036A (zh) * 2013-03-15 2021-06-11 维普詹尼克斯公司 新型镇痛组合物
US20150321770A1 (en) * 2014-03-09 2015-11-12 Davy Zide Qian New method to prevent or stop an airplane from being hijacked and to minimize the effect of damage by using remote and wireless real-time monitoring and inhalational general anesthetic gases controlled from the ground (level)
CN104841025B (zh) * 2015-04-16 2017-10-24 河南科技大学第一附属医院 一种用于密闭腰椎穿刺及脑脊液置换的装置
EP3325063B1 (en) 2015-07-20 2022-10-05 Medical Developments International Limited Inhaler device for inhalable liquids
KR102574310B1 (ko) 2015-07-20 2023-09-05 메디컬 디벨롭먼츠 인터네셔널 리미티드 흡입가능한 액체를 위한 흡입기 장치
US20180200459A1 (en) 2015-07-20 2018-07-19 Medical Developments International Limited Inhaler device for inhalable liquids
US11571526B2 (en) 2016-09-06 2023-02-07 Medical Developments International Limited Inhaler device for inhalable liquids
CN110141508A (zh) * 2019-05-20 2019-08-20 崔文馨 无菌净化空气生理盐水
WO2023217384A1 (en) 2022-05-13 2023-11-16 Laboratorios Gebro Pharma, S.A. Pharmaceutical composition for topical administration comprising a volatile anaesthetic

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786675A (fr) * 1971-08-02 1973-01-25 Airco Inc Separation d'oxydes d'alkyle halogenes par distillation azeotropique.
US4109651A (en) * 1975-11-19 1978-08-29 Steigerwald Allan M Anesthetic gas exhaust system
US4453951A (en) * 1980-07-09 1984-06-12 General Electric Co. Process for the production of silicone carbide composite
SE8008962L (sv) * 1980-12-18 1982-06-19 Erik Allan Lindkvist Anordning vid narkosmask
US4879062A (en) 1981-10-20 1989-11-07 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4744989A (en) 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5114715A (en) * 1990-11-29 1992-05-19 Sepracor Inc. Methods of use and compositions of (s)-isoflurane and (s)-desflurane
US5114714A (en) * 1990-11-29 1992-05-19 Sepracor, Inc. Methods of use and compositions of (r)-isoflurane and (r)-desflurane
DE4105972C2 (de) * 1991-02-26 1999-06-02 Draegerwerk Ag Narkosemitteldosiervorrichtung
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5230778A (en) * 1992-05-01 1993-07-27 Gavlin Associates Purification of isoflurane by extractive distillation
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9308306D0 (en) * 1993-04-22 1993-06-09 Univ Aberdeen Analgesic composition
JPH09501156A (ja) * 1993-07-30 1997-02-04 ザ．ウェルカム．ファウンデーション．リミテッド 治療法で使用するピペラジン化合物
GB9423542D0 (en) 1994-11-22 1995-01-11 Marples Brian A Pharmaceutical compounds
US5568910A (en) * 1995-03-02 1996-10-29 Delmarva Laboratories, Inc. Anesthesia machine
US6248788B1 (en) * 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5874469A (en) 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5919826A (en) 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
MXPA99011298A (es) 1997-07-14 2004-10-28 Adolor Corp Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US5976072A (en) * 1998-01-29 1999-11-02 Johns Hopkins University Copa method for fiberoptic endotracheal intubation
AR015744A1 (es) 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6869440B2 (en) * 1999-02-09 2005-03-22 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
US6830581B2 (en) * 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
US6653354B2 (en) * 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
US6706034B1 (en) * 1999-12-30 2004-03-16 Advanced Cardiovascular Systems, Inc. Process for agent retention in biological tissues
US6669954B2 (en) * 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
CA2407797A1 (en) 2000-05-02 2001-11-08 Action Pharma Aps Methods for treatment of diseases associated with inflammation under non-ischemic conditions
US6770636B2 (en) * 2000-08-18 2004-08-03 Boehringer Ingelheim Pharma Kg Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines
WO2002085308A2 (en) 2001-04-24 2002-10-31 Epigenesis Pharmaceuticals, Inc. Antisense and anti-inflammatory based compositions to treat respiratory disorders
US7758890B2 (en) * 2001-06-23 2010-07-20 Lyotropic Therapeutics, Inc. Treatment using dantrolene
BR0306820A (pt) 2002-01-10 2004-12-07 Pharmacia & Up John Company Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrus
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
AU2003219167A1 (en) 2002-03-19 2003-09-29 Genset Sa Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists
WO2005016955A2 (en) 2003-08-07 2005-02-24 Biogen Idec Ma Inc. Nogo receptor antagonists
BR0313331A (pt) 2002-08-10 2007-07-24 Univ Yale antagonistas de receptor de nogo
JP5210486B2 (ja) * 2002-10-11 2013-06-12 バクスター・インターナショナル・インコーポレイテッド ハロゲン化揮発性麻酔剤の静脈投与による、心臓保護および神経保護のための方法
EP1613321A2 (en) 2003-03-28 2006-01-11 Acadia Pharmaceuticals Inc. Muscarinic m1 receptor agonists for pain management
WO2004100868A2 (en) 2003-04-23 2004-11-25 Abbott Laboratories Method of treating transplant rejection
US20030173287A1 (en) * 2003-05-06 2003-09-18 Johnston Arthur W Filter devices and methods of use
WO2004103299A2 (en) 2003-05-16 2004-12-02 Acorda Therapeutics, Inc. Compositions and methods for the treatment of cns injuries
DE602004013792D1 (de) 2003-08-15 2008-06-26 Ab Science Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
DE602004017487D1 (de) 2003-08-29 2008-12-11 Childrens Medical Center Antiangiogene peptide vom n-terminus von endostatin
CA2539753A1 (en) 2003-09-25 2005-04-07 Acadia Pharmaceuticals Inc. Treating neuropathic pain with neuropeptide ff receptor 2 agonists
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TW200633990A (en) 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20080312145A1 (en) 2004-12-16 2008-12-18 Anges Mg, Inc. Agent for Regulating Bone Formation
WO2006088088A1 (ja) 2005-02-16 2006-08-24 Astellas Pharma Inc. Ｒｏｃｋ阻害剤を含有する疼痛治療剤
EP2099408B1 (en) 2006-11-28 2016-10-05 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
EP3581169A1 (en) 2008-01-22 2019-12-18 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
WO2009094460A2 (en) 2008-01-22 2009-07-30 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
WO2010129686A1 (en) 2009-05-05 2010-11-11 Vapogenix, Inc. Novel formulations of volatile anesthetics and methods of use for reducing inflammation

Also Published As

Publication number Publication date
CA2663857A1 (en) 2008-03-27
CA2663857C (en) 2017-10-31
JP2016041721A (ja) 2016-03-31
DK2081562T3 (en) 2016-05-30
US10357464B2 (en) 2019-07-23
WO2008036858A3 (en) 2008-08-07
JP2014074028A (ja) 2014-04-24
EP2081562A2 (en) 2009-07-29
ES2573253T3 (es) 2016-06-06
JP2017218450A (ja) 2017-12-14
AU2007299738A1 (en) 2008-03-27
US20190358173A1 (en) 2019-11-28
AU2007299738B2 (en) 2013-03-28
US20110269843A1 (en) 2011-11-03
JP5827658B2 (ja) 2015-12-02
JP6312146B2 (ja) 2018-04-18
US10799466B2 (en) 2020-10-13
EP2081562B1 (en) 2016-02-24
JP2010504359A (ja) 2010-02-12
US20080119820A1 (en) 2008-05-22
WO2008036858A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
PL2081562T3 (pl) Sposoby dostarczania lotnych środków znieczulających do znieczulenia regionalnego i/lub zmniejszania bólu
PL2244737T3 (pl) Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu
EP1962704A4 (en) DRY BONE PLATE AND METHOD AND TARGETING DEVICE FOR USE THEREOF
IL262918A (en) A method and system for inserting a medical device into a selected location within a perforation
PL2046419T3 (pl) Kaniula i urządzenie dostarczające
IL177924A0 (en) Method and system for delivering a medical device to a selected position within a lumen
EP2358325A4 (en) ANALGESIC IMPLANT DEVICE AND SYSTEM
IL205196A0 (en) Implant delivery device and method
EP2104525A4 (en) HYPODERMIC RESERVOIR AND APPARATUS FOR DRUG DELIVERY
EP1858583A4 (en) BLOCKABLE PRECHARGE STIMULATION CATHETER FOR ADMINISTRATION OF ANESTHESIC DRUGS
EP2134409A4 (en) IMPLANTABLE MEDICINAL PRODUCT AND METHOD AND METHOD FOR THE APPLICATION THEREOF
EP2367589A4 (en) SURGICAL MASK COMBINED WITH ANESTHESIA AND GAS RECOVERY
EP2222359A4 (en) DEVICES AND METHOD FOR TREATMENT OF BREATHING IN SLEEP
WO2008151299A3 (en) Implantable medical devices for local and regional treatment
EP2010246A4 (en) DEVICE AND METHOD FOR DRUG DELIVERY
IL201046A0 (en) Method and device for drug delivery
EP2200686A4 (en) Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
EP2184986A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
ZA200903649B (en) Devices and methods for ophthalmic drug delivery
GB0814833D0 (en) Method and device for treating sleep apnea
GB0816111D0 (en) Implant and delivery system for soft tissue repair
PL2244783T3 (pl) Kompozycje lotnego anestetyku i sposoby stosowania
EP2109432A4 (en) PATIENT REPOSITIONING AND LIMBING EQUIPMENT SYSTEM
PL1870641T3 (pl) Urządzenie odparowujące i sposób eksploatacji urządzenia odparowującego
IL198723A0 (en) Methods and compositions for therapeutic treatment